A truncated fragment of Ov-ASP-1 consisting of the core pathogenesis-related-1 (PR-1) domain maintains adjuvanticity as the full-length protein
Abstract
No abstract availableKeywords
Funding Information
- NSFC (31000412)
This publication has 38 references indexed in Scilit:
- Flagellin Induces Antibody Responses through a TLR5- and Inflammasome-Independent PathwayThe Journal of Immunology, 2014
- A synthetic chimeric peptide harboring human papillomavirus 16 cytotoxic T lymphocyte epitopes shows therapeutic potential in a murine model of cervical cancerImmunologic Research, 2013
- Adjuvants containing natural and synthetic Toll-like receptor 4 ligandsExpert Review of Vaccines, 2013
- Salmonella typhi Ty21a bacterial ghost vector augments HIV-1 gp140 DNA vaccine-induced peripheral and mucosal antibody responses via TLR4 pathwayVaccine, 2012
- Adjuvants for human vaccinesCurrent Opinion in Immunology, 2012
- DNA released from dying host cells mediates aluminum adjuvant activityNature Medicine, 2011
- The CAP Superfamily: Cysteine-Rich Secretory Proteins, Antigen 5, and Pathogenesis-Related 1 Proteins—Roles in Reproduction, Cancer, and Immune DefenseEndocrine Reviews, 2008
- A novel synthetic adjuvant effectively enhances the immunogenicity of the influenza vaccineVaccine, 2006
- Synthetic double-stranded RNA poly(I:C) as a potent peptide vaccine adjuvant: therapeutic activity against human cervical cancer in a rodent modelCancer Immunology, Immunotherapy, 2005
- Lacto- N -fucopentaose III Found on Schitosoma mansoni Egg Antigens Functions as Adjuvant for Proteins by Inducing Th2-Type ResponseThe Journal of Immunology, 2001